BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 34715880)

  • 1. The prognostic value of arginase-1 and glypican-3 expression levels in patients after surgical intrahepatic cholangiocarcinoma resection.
    Qiang Z; Zhang H; Jin S; Yan C; Li Z; Tao L; Yu H
    World J Surg Oncol; 2021 Oct; 19(1):316. PubMed ID: 34715880
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of stroma LOXL2 overexpression on the prognosis of intrahepatic cholangiocarcinoma.
    Bergeat D; Fautrel A; Turlin B; Merdrignac A; Rayar M; Boudjema K; Coulouarn C; Sulpice L
    J Surg Res; 2016 Jun; 203(2):441-50. PubMed ID: 27363654
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preoperative gamma-glutamyltransferase to lymphocyte ratio predicts long-term outcomes in intrahepatic cholangiocarcinoma patients following hepatic resection.
    Wang JJ; Li H; Li JX; Xu L; Wu H; Zeng Y
    World J Gastroenterol; 2020 Apr; 26(13):1501-1512. PubMed ID: 32308350
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical Characteristics and Prognostic Factors of Patients with Intrahepatic Cholangiocarcinoma with Fever: A Propensity Score Matching Analysis.
    Gong ZJ; Cheng JW; Gao PT; Huang A; Sun YF; Zhou KQ; Hu B; Qiu SJ; Zhou J; Fan J; Yang XR
    Oncologist; 2019 Jul; 24(7):997-1007. PubMed ID: 30910867
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The prognostic value of sarcopenia combined with preoperative fibrinogen-albumin ratio in patients with intrahepatic cholangiocarcinoma after surgery: A multicenter, prospective study.
    Yu H; Wang M; Wang Y; Yang J; Deng L; Bao W; He B; Lin Z; Chen Z; Chen K; Zhang B; Liu F; Yu Z; Ye L; Jin B; Chen G
    Cancer Med; 2021 Jul; 10(14):4768-4780. PubMed ID: 34105304
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The prognostic value of sarcopenia combined with hepatolithiasis in intrahepatic cholangiocarcinoma patients after surgery: A prospective cohort study.
    Deng L; Wang Y; Zhao J; Tong Y; Zhang S; Jin C; Chen K; Bao W; Yu Z; Chen G
    Eur J Surg Oncol; 2021 Mar; 47(3 Pt B):603-612. PubMed ID: 32933804
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of surgical treatment and poor prognostic factors for patients with intrahepatic cholangiocarcinoma: retrospective analysis of 60 patients.
    Yamashita Y; Taketomi A; Morita K; Fukuhara T; Ueda S; Sanefuji K; Iguchi T; Kayashima H; Sugimachi K; Maehara Y
    Anticancer Res; 2008; 28(4C):2353-9. PubMed ID: 18751418
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Negative impact of preoperative platelet-lymphocyte ratio on outcome after hepatic resection for intrahepatic cholangiocarcinoma.
    Chen Q; Dai Z; Yin D; Yang LX; Wang Z; Xiao YS; Fan J; Zhou J
    Medicine (Baltimore); 2015 Apr; 94(13):e574. PubMed ID: 25837750
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of downregulation of WWOX with poor prognosis in patients with intrahepatic cholangiocarcinoma after curative resection.
    Huang C; Tian Y; Peng R; Zhang C; Wang D; Han S; Jiao C; Wang X; Zhang H; Wang Y; Li X
    J Gastroenterol Hepatol; 2015 Feb; 30(2):421-33. PubMed ID: 25168293
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Retrospective analysis of histopathologic prognostic factors after hepatectomy for intrahepatic cholangiocarcinoma.
    Jiang BG; Sun LL; Yu WL; Tang ZH; Zong M; Zhang YJ
    Cancer J; 2009; 15(3):257-61. PubMed ID: 19556914
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of intrahepatic cholangiocarcinoma after curative resection: outcome, prognostic factor, and recurrence.
    Chan KM; Tsai CY; Yeh CN; Yeh TS; Lee WC; Jan YY; Chen MF
    BMC Gastroenterol; 2018 Dec; 18(1):180. PubMed ID: 30514231
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Survival rate of intrahepatic cholangiocarcinoma patients after surgical treatment in Thailand.
    Sriputtha S; Khuntikeo N; Promthet S; Kamsa-Ard S
    Asian Pac J Cancer Prev; 2013; 14(2):1107-10. PubMed ID: 23621195
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intrahepatic cholangiocarcinoma: prognostic factors after surgical resection.
    Guglielmi A; Ruzzenente A; Campagnaro T; Pachera S; Valdegamberi A; Nicoli P; Cappellani A; Malfermoni G; Iacono C
    World J Surg; 2009 Jun; 33(6):1247-54. PubMed ID: 19294467
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Prediction of prognosis of patients with radical resection of intrahepatic cholangiocarcinoma based on single cell omics].
    Chen JL; Tang Y; Qin DL; Li ZL; Tang ZH; Quan ZW
    Zhonghua Wai Ke Za Zhi; 2024 Apr; 62(4):316-323. PubMed ID: 38432673
    [No Abstract]   [Full Text] [Related]  

  • 15. Does intrahepatic cholangiocarcinoma have better prognosis compared to perihilar cholangiocarcinoma?
    Guglielmi A; Ruzzenente A; Campagnaro T; Pachera S; Valdegamberi A; Capelli P; Pedica F; Nicoli P; Conci S; Iacono C
    J Surg Oncol; 2010 Feb; 101(2):111-5. PubMed ID: 19953578
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coagulopathy associated with poor prognosis in intrahepatic cholangiocarcinoma patients after curative resection.
    Wang H; Liu W; Tian M; Tang Z; Jiang X; Zhou P; Ding Z; Peng Y; Dai Z; Qiu S; Zhou J; Fan J; Shi Y
    Biosci Trends; 2017 Sep; 11(4):469-474. PubMed ID: 28781265
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High Beclin-1 and ARID1A expression corelates with poor survival and high recurrence in intrahepatic cholangiocarcinoma: a histopathological retrospective study.
    Bi C; Liu M; Rong W; Wu F; Zhang Y; Lin S; Liu Y; Wu J; Wang L
    BMC Cancer; 2019 Mar; 19(1):213. PubMed ID: 30849962
    [TBL] [Abstract][Full Text] [Related]  

  • 18. EYA4 gene functions as a prognostic marker and inhibits the growth of intrahepatic cholangiocarcinoma.
    Hao XY; Cai JP; Liu X; Chen W; Hou X; Chen D; Lai JM; Liang LJ; Yin XY
    Chin J Cancer; 2016 Jul; 35(1):70. PubMed ID: 27469137
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic value of glypican-3, arginase-1 and hepatocyte paraffin antigen -1 in differentiating hepatocellular carcinoma from intrahepatic cholangiocarcinoma.
    Wang C; Shao X; Zhang X; Xie C; Yu J; Xu X; Yang J; Li Y; Xu W
    Transl Cancer Res; 2020 Jan; 9(1):128-136. PubMed ID: 35117166
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevated expression of G
    Cao XY; Ji HJ; Zhou YJ; Lu XF; Shen JY; Wu ZR; Bu H; Shi YJ
    Hepatobiliary Pancreat Dis Int; 2017 Dec; 16(6):638-644. PubMed ID: 29291784
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.